DT-7012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DT-7012, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors [Phase 1, Phase 2]